John Lieske, MD
Enriched profileProfessor of Medicine, Mayo Clinic College of Medicine and Science · Mayo Clinic
John Lieske is Professor of Medicine, Mayo Clinic College of Medicine and Science at Mayo Clinic. OpenAlex indexes 587 publications with 23,085 citations (h-index 82); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Data verified 16 Oct 2026
Overview
Updated 16 Oct 2026
John C. Lieske, M.D., is Professor of Medicine, Mayo Clinic College of Medicine and Science. The public record shows 587 publications with 23,085 citations (h-index 82), centered on Kidney Stones and Urolithiasis Treatments, Chronic Kidney Disease and Diabetes, Pediatric Urology and Nephrology Studies. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 7 companies, 14 NIH-funded awards (2000–2026).
- Most recent indexed publication: 2026 · Clinical journal of the American Society of Nephrology
- Top research focus: Kidney Stones and Urolithiasis Treatments
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 7 companies
Generated from the cited public record · current as of 16 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 33 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 302.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 16 Oct 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Prospective Research Rare Kidney Stones (ProRKS)
Sponsor: Mayo Clinic
- Hydroxyproline Influence on Oxalate Metabolism
Sponsor: Mayo Clinic
Industry payments
Updated 16 Oct 2026
7 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20253 payments
- BioMarin Pharmaceutical Inc.Program year20241 payment
- Novo Nordisk IncProgram year20242 payments
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
62.8%Thiazide-like diuretic26.1%Indapamide63%Chlorthalidone37%Part D<11 patientsAngiotensin receptor blocker (ARB)10.1%Losartan Potassium100%Part D<11 patients+ 3 more classes in this area
Metabolism & gastrointestinal
30%Metabolic Alkalinizer23.2%Potassium Citrate Er100%Part D≥16 patientsPotassium supplement6.8%Potassium Chloride100%Part D<11 patientsMusculoskeletal
7.2%Xanthine oxidase inhibitor7.2%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 16 Oct 2026
14 NIH research awards on record, funded 2000–2026 per NIH RePORTER. The latest:
- An individualized medicine approach to urinary stone disease
Mayo Clinic Rochester
FY2026$818,020R01DK133171 - Next Generation KUH Researchers (GENERATOR) Admin Core
Mayo Clinic Rochester
FY2026$256,921U2CDK143937
Publications
Updated 16 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Final Results of the ILLUMINATE-A Phase 3 Clinical Trial of Lumasiran for Primary Hyperoxaluria 1.
Clinical journal of the American Society of Nephrology
Clinical Trial2026 - The Significance of Fibroblast Growth Factor 23 and 24,25-Dihydroxyvitamin D in Dent Disease Type 1.
Clinical journal of the American Society of Nephrology
Article2026 - Measurement, Estimation, and Correlates of the GFR before and after Bariatric Surgery.
Journal of the American Society of Nephrology
Article2026
Most-cited works
by citation count (OpenAlex)- 01Rituximab or Cyclosporine in the Treatment of Membranous NephropathyArticle604 citations2019
- 02Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1Article506 citations2021
- 03The Substantial Loss of Nephrons in Healthy Human Kidneys with AgingArticle443 citations2016
- 04Kidney Stones and the Risk for Chronic Kidney DiseaseArticle435 citations2009
- 05Noninvasive Differentiation of Uric Acid versus Non–Uric Acid Kidney Stones Using Dual-Energy CTArticle395 citations2007
Network
Updated 16 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 16 Oct 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/john-lieske-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - X / Twitter
x.com/lieske_john
Mentions by others
where others cite or feature them- Facebook
facebook.com/MayoClinic/videos/kidney-stone-prevention-mayo-clinic-radio/2386033878390328
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗ - Other
auau.auanet.org/node/28513/bio/2517/view
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →auau.auanet.org ↗ - Other
news.mayocliniclabs.com/2025/06/24/assay-aids-diagnosis-of-resistant-hypertension-john-lieske-m-d-and-sandra-taler-m-d
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.mayocliniclabs.com ↗ - Other
mayo.edu/research/faculty/lieske-john-c-m-d/bio-00027820
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗ - Other
mayoclinic.org/biographies/lieske-john-c-m-d/bio-20054296
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 16 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- M.D.
University of Chicago Division of the Biological Sciences, The Pritzker School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗ - Board Certified
Internal Medicine (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗ - Board Certified
Nephrology (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayoclinic.org ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →asn-online.org ↗
Secondary affiliations
appointments beyond the home institution- Director
Renal Function Laboratory, Department of Laboratory Medicine and Pathology, Mayo Clinic
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗ - Principal Investigator
Mayo Clinic O'Brien Urology Research Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗ - Assistant Director
Rare Kidney Stone Consortium (Director, Dent Disease component)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mayo.edu ↗ - Site Principal Investigator
United States Urinary Stone Disease Research Network (USDRN), Mayo Clinic recruiting site
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →usdrn.org ↗
Media & interviews
press, podcasts and appearances- Guest
Mayo Clinic Radio podcast/video segment "Kidney stone prevention," discussing kidney stone formation, treatment, and a Mayo prevention study
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗ - Featured physician
"Mayo Clinic Minute: Avoiding kidney stones" video on hydration and stone prevention
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newsnetwork.mayoclinic.org ↗ - Featured researcher
Mayo Clinic News Network feature/documentary "A World in a Grain of Sand: New Discoveries in Kidney Stones"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →newsnetwork.mayoclinic.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
S Rajkumar, MD
Mayo Clinic
Bradley Boeve, MD
Mayo Clinic
Victor Montori, MD
Mayo Clinic
Ayalew Tefferi, MD
Mayo Clinic
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)